Asthma treatment with inhaler plus immune-modulating tablet
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether adding an immune-modulating tablet (made from bacteria) to a standard combination inhaler for asthma improves asthma control more than the inhaler alone. The study aims to see if this combination helps reduce symptoms and lung inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years or older.
- You have had a confirmed asthma diagnosis for at least 6 months.
- Your asthma is not fully controlled (for example, symptoms occur more than twice a week, or you need rescue inhaler more than twice a week).
- In the past 6 months, a lung function test showed your airways respond to medication or are overly sensitive.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control during the study.
- You have not used immune-modulating medications (such as thymosin or bacterial extracts) in the last 30 days and can avoid them during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways to use common asthma inhalers (budesonide and formoterol) to see if a simple, everyday approach can control mild asthma symptoms better and with less need for rescue medicine.
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This study tests a new inhaled medication (given through a device you breathe in) for adults with asthma. It is designed to reduce inflammation and improve breathing, and may help people who have not found relief with standard daily inhalers.
This study tests a new way to treat asthma flares in children and teens (ages 6–18) with mild-to-moderate asthma. It aims to see if a quick-relief anti-inflammatory medicine works better than current treatments to prevent severe attacks.
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.